Suppr超能文献

Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?

作者信息

Mazzatenta C, Piccolo V, Pace G, Romano I, Argenziano G, Bassi A

机构信息

UO Dermatologia Lucca- Azienda USL Toscana Nordovest, Lucca, Italy.

Dermatology Unit, University of Campania Luigi Vanvitelli, Naples, Italy.

出版信息

J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.

Abstract
摘要

相似文献

1
Purpuric lesions on the eyelids developed after BNT162b2 mRNA COVID-19 vaccine: another piece of SARS-CoV-2 skin puzzle?
J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e543-e545. doi: 10.1111/jdv.17340. Epub 2021 May 28.
2
Pigmented purpuric dermatosis after BNT162B2 mRNA COVID-19 vaccine administration.
J Cosmet Dermatol. 2022 Feb;21(2):435-437. doi: 10.1111/jocd.14607. Epub 2021 Nov 17.
3
BNT162b2 mRNA COVID-19 vaccine-induced chilblain-like lesions reinforces the hypothesis of their relationship with SARS-CoV-2.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e493-e494. doi: 10.1111/jdv.17320. Epub 2021 May 10.
4
Skin ulcer at the injection site of BNT162b2 mRNA COVID-19 vaccine.
J Dermatol. 2021 Dec;48(12):e596-e597. doi: 10.1111/1346-8138.16163. Epub 2021 Sep 21.
5
Cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine.
Int J Dermatol. 2021 Jul;60(7):891-892. doi: 10.1111/ijd.15575. Epub 2021 Apr 14.
7
Dynamics of antibody response to BNT162b2 mRNA COVID-19 vaccine after 6 months.
J Travel Med. 2021 Dec 29;28(8). doi: 10.1093/jtm/taab173.
9
Eosinophilic cellulitis after BNT162b2 mRNA Covid-19 vaccine.
J Eur Acad Dermatol Venereol. 2022 Jan;36(1):e26-e28. doi: 10.1111/jdv.17685. Epub 2021 Oct 5.
10
Safety and BNT162b2 mRNA COVID-19 vaccination.
Acta Biomed. 2022 Jan 19;92(6):e2021485. doi: 10.23750/abm.v92i6.12359.

引用本文的文献

1
COVID and COVID vaccine-related corneal morbidity: A review.
Indian J Ophthalmol. 2023 Dec 1;71(12):3595-3599. doi: 10.4103/IJO.IJO_765_23. Epub 2023 Nov 20.
2
Lower Eyelid Complication After Blepharoplasty and COVID-19 Vaccination.
Aesthetic Plast Surg. 2023 Dec;47(6):2573-2578. doi: 10.1007/s00266-023-03532-7. Epub 2023 Aug 14.
3
Can COVID-19 Vaccines Induce Premature Non-Communicable Diseases: Where Are We Heading to?
Vaccines (Basel). 2023 Jan 17;11(2):208. doi: 10.3390/vaccines11020208.
4
Unilateral Acute Central Serous Chorioretinopathy with Inactivated Coronavirus Disease 2019 Vaccination: A Case Report and Review of Literature.
J Curr Ophthalmol. 2022 Nov 30;34(3):373-378. doi: 10.4103/joco.joco_41_22. eCollection 2022 Jul-Sep.
5
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know so Far?
Dermatol Pract Concept. 2022 Oct 1;12(4):e2022170. doi: 10.5826/dpc.1204a170. eCollection 2022 Nov.
6
Pfizer-BioNTech (BNT162b2), Moderna (mRNA-1273) COVID-19 mRNA vaccines and hypersensitivity reactions.
J Natl Med Assoc. 2022 Dec;114(6):601-612. doi: 10.1016/j.jnma.2022.08.003. Epub 2022 Oct 28.
7
Ocular adverse effects of COVID-19 vaccines: A systematic review.
J Family Med Prim Care. 2022 Sep;11(9):5041-5054. doi: 10.4103/jfmpc.jfmpc_747_22. Epub 2022 Oct 14.
8
Evaluation of the Effect of İnfection and İmmunity on the Tear Film by Scheimpflug-Placido Disc Topography- A Case Control Study.
Photodiagnosis Photodyn Ther. 2023 Mar;41:103216. doi: 10.1016/j.pdpdt.2022.103216. Epub 2022 Dec 5.
10
COVID-19 Vaccine-Associated Ocular Adverse Effects: An Overview.
Vaccines (Basel). 2022 Nov 7;10(11):1879. doi: 10.3390/vaccines10111879.

本文引用的文献

1
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
2
Transient cutaneous manifestations after administration of Pfizer-BioNTech COVID-19 Vaccine: an Italian single-centre case series.
J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e483-e485. doi: 10.1111/jdv.17268. Epub 2021 Apr 24.
4
Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
Am J Hematol. 2021 May 1;96(5):534-537. doi: 10.1002/ajh.26132. Epub 2021 Mar 9.
5
Chilblain-like lesions and COVID-19: second wave, second outbreak.
J Eur Acad Dermatol Venereol. 2021 May;35(5):e316-e318. doi: 10.1111/jdv.17145. Epub 2021 Mar 2.
7
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients.
J Am Acad Dermatol. 2020 Dec;83(6):1749-1751. doi: 10.1016/j.jaad.2020.07.058. Epub 2020 Sep 30.
8
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.
Cell. 2020 Oct 1;183(1):158-168.e14. doi: 10.1016/j.cell.2020.08.017. Epub 2020 Aug 14.
9
Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
Int J Dermatol. 2020 Aug;59(8):1026-1027. doi: 10.1111/ijd.14993. Epub 2020 Jun 4.
10
Acral findings during the COVID-19 outbreak: Chilblain-like lesions should be preferred to acroischemic lesions.
J Am Acad Dermatol. 2020 Sep;83(3):e231. doi: 10.1016/j.jaad.2020.05.077. Epub 2020 May 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验